Similar results have been reported at the protein level in the cerebral cortex of patients with AD [20], where mGlu1 activity is down-regulated (with no changes in mGlu5) by significant decrease in its expression levels, which correlated with severity of the disease. This evidence concerns the gene GRM1 and Alzheimer disease.